Market View 12th July 2022

View on market: Stay Cautious, be with quality business:

Asian stocks were mostly lower Tuesday amid concerns that the upcoming earnings season, a looming U.S. inflation print and China’s struggle with Covid will stoke worries about economic prospects. The U.S. dollar rose the most in a month to rise to an over 2-year high, spurring the Euro to close in on parity, amid gas shortage and fears of economic recession. Japan led the regional decline, while Hong Kong futures were also in the red following the worst drop in U.S.-traded Chinese shares since May. U.S. contracts wavered after technology shares led a Wall Street slide, including a plunge in Twitter Inc. as Elon Musk walked away from his deal to buy the firm. As of 7:30 a.m., the Singapore-traded SGX Nifty — an early barometer of India’s benchmark Nifty 50 — fell 0.70% to 16,085.50.  Treasuries extended gains, taking the US 10-year yield to 2.98%. Crude oil shed 1%. Bitcoin dropped back below the $20,000 level.

Economic Calendar:

• INR: WPI Inflation 14^th July 2022.
• INR: IIP Data 12^th July 2022.
• USD: OPEC Monthly Report 12^th July, 2022.
• USD: Core CPI 13^th July, 2022.

Q1FY23 Result Today: HCL Technologies, Sterling and Wilson Renewable Energy, National Standard (India), Delta Corp, Anand Rathi Wealth

Q1FY23 Result

Spandana Sphoorty: Financial Q4 FY22 (Consolidated, YoY) Revenue fell 39% at Rs 286.82 crore Vs Rs 473.91 crore EBIT fell 33% at Rs 133.45 crore Vs Rs 198.85 crore EBIT margin 46.5% Vs 42% Net profit fell 42% at Rs 28.44 crore Vs Rs 49.06 crore

5 Paisa Capital Q1FY23 (QoQ) Revenue at Rs 84 crore vs Rs 88 crore Profit before tax at Rs 10 crore vs Rs 6 crore Net profit at Rs 7 crore vs Rs 4 crore

Brokerage Radar:

CLSA ON ACC/AMBUJA: Expect both to U-P following conclusion of open offer Ambuja/ACC are +2%/-3% over past 3 mths vs peers down 11%-21% & Nifty down 8%, due to acquisition by Adani Group Post-open offer focus will shift to near-term fundamentals ACC-TP Rs 2300 Ambuja- TP Rs 375.

CLSA ON APOLLO HOSPITAL: O-P, TP Rs 4470 Management reiterated its mid-teen rev growth guidance for hospitals through a mix of ARPOB growth & increased occupancies Its offline pharmacy has potential to grow rev c.20% YoY & its cash flows will help to invest in its digital biz
CREDIT SUISSE ON STAR HEALTH: O-P. Tp Rs 600 Continue to believe Star’s large & growing agent base (3x of next life/GI player) & hospital network (12,000+) with pricing arrangements provide a partial moat &keeps it better placed to withstand competitive pressures.

KOTAK INST EQUITY ON NMDC: Reduce, TP Rs 105 NMDC has cut its prices by 36% in May-June 2022 on imposition of export duty and we expect further weakness given a 20% correction in seaborne iron ore prices in past one month, Sales vol have significantly contracted in 1QFY23, led by destocking by consumers, & likely to recover in 2HFY23E Believe recent stock underperformance captures sharp margin contraction from 2QFY23E onwards

International Markets:

U.S & Europe:

Asian markets:

ADR Watch:

Commodities & Currency

FIIs & DII:

News Update:

Eureka Forbes: The company appointed Pratik Pota as Managing Director and Chief Executive Officer for a term of five years effective from August 16. The appointment was made following current MD and CEO Marzin R Shroff’s resignation.

Star Health and Allied Insurance: The company has partnered with Common Services Centers, under Ministry of Electronics & Information Technology, to expand the insurance products to rural customers, across tier-II, tier-III cities and rural markets pan India.

Power Grid: The company has placed B.S. Jha under suspension with effect from July 5 after his arrest by CBI. The company said that it was not aware of any negotiations and that there is no material impact on the company.

Borosil Renewables: The company will consider fund raising through further public offer, issuance of American Depository Receipts or Global Depository Receipts, issuance of Foreign Currency Convertible Bonds, qualified institutions placement or through a combination on July 14.

Source: Moneycontrol, Livemint,, Bloomberg, Investing

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Israil Khan, Elite Wealth Limited, suhail@elitewealth.in
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.
Company-Specific Disclosures
Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or emailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.
Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.
Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.
Country Specific Disclosures
India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone:011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in
EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
1. Reports
a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
2. Compensation
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL